HealthMyne’s radiomic and quantitative imaging solution receives scientific validation from a study published in Cancer Control

April 9, 2021 | Article

Multiple researchers from academic medical institutions across Italy analyzed HealthMyne's radiomic and quantitative imaging solution for use in lung carcinoma. The study demonstrated HealthMyne's quantitative volumetric delineation was consistent and that several radiomic metrics extracted by the tool were significant and robust predictors of RECIST response.